Association between patient ethnicity and prostate cancer diagnosis following a prostate-specific antigen test: a cohort study of 730,000 men in primary care in the UK
dc.contributor.author | Down, L | |
dc.contributor.author | Barlow, M | |
dc.contributor.author | Bailey, SER | |
dc.contributor.author | Mounce, LTA | |
dc.contributor.author | Merriel, SWD | |
dc.contributor.author | Watson, J | |
dc.contributor.author | Martins, T | |
dc.date.accessioned | 2024-03-06T11:17:40Z | |
dc.date.issued | 2024-03-01 | |
dc.date.updated | 2024-03-06T10:30:07Z | |
dc.description.abstract | BACKGROUND: Black men have higher prostate-specific antigen (PSA) levels and higher prostate cancer incidence and mortality than White men, while Asian men tend to have lower prostate cancer incidence and mortality than White men. Much of the evidence comes from the USA, and information from UK populations is limited. METHODS: This retrospective cohort study used data on patients registered at general practices in England contributing to the Clinical Practice Research Datalink (CPRD) Aurum dataset. Those eligible were men aged 40 and over with a record of ethnicity and a PSA test result recorded between 2010 and 2017 with no prior cancer diagnosis. The aim was to assess the incidence of prostate cancer following a raised PSA test result in men from different ethnic groups. Additionally, incidence of advanced prostate cancer was investigated. Cancer incidence was estimated from multi-level logistic regression models adjusting for potential confounding factors. RESULTS: 730,515 men with a PSA test were included (88.9% White). Black men and men with mixed ethnicity had higher PSA values, particularly for those aged above 60 years. In the year following a raised PSA result (using age-specific thresholds), Black men had the highest prostate cancer incidence at 24.7% (95% CI 23.3%, 26.2%); Asian men had the lowest at 13.4% (12.2%, 14.7%); incidence for White men was 19.8% (19.4%, 20.2%). The peak incidence of prostate cancer for all groups was in men aged 70-79. Incidence of prostate cancer diagnosed at an advanced stage was similar between Black and White men. CONCLUSIONS: More prostate cancer was diagnosed in Black men with a raised PSA result, but rates of advanced prostate cancer were not higher in this group. In this large primary care-based cohort, the incidence of prostate cancer in men with elevated PSA levels increases with increasing age, even when using age-adjusted thresholds, with Black men significantly more likely to be diagnosed compared to White or Asian men. The incidence of advanced stage prostate cancer at diagnosis was similar for Black and White men with a raised PSA result, but lower for Asian men. | en_GB |
dc.description.sponsorship | Cancer Research UK | en_GB |
dc.description.sponsorship | National Institute for Health and Care Research (NIHR) | en_GB |
dc.identifier.citation | Vol. 22, article 82 | en_GB |
dc.identifier.doi | https://doi.org/10.1186/s12916-024-03283-5 | |
dc.identifier.grantnumber | EDDCPJT/100031 | en_GB |
dc.identifier.grantnumber | project reference 511 | en_GB |
dc.identifier.grantnumber | C56361/A26124 | en_GB |
dc.identifier.grantnumber | FR5/604 | en_GB |
dc.identifier.grantnumber | NIHR301666 | en_GB |
dc.identifier.uri | http://hdl.handle.net/10871/135490 | |
dc.identifier | ORCID: 0000-0003-0020-4778 (Bailey, Sarah ER) | |
dc.identifier | ORCID: 0000-0002-6089-0661 (Mounce, Luke TA) | |
dc.identifier | ORCID: 0000-0001-5226-4073 (Martins, Tanimola) | |
dc.language.iso | en | en_GB |
dc.publisher | BMC | en_GB |
dc.relation.url | https://www.ncbi.nlm.nih.gov/pubmed/38424555 | en_GB |
dc.rights | © The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. | en_GB |
dc.subject | Blood tests | en_GB |
dc.subject | Ethnicity | en_GB |
dc.subject | Health inequities | en_GB |
dc.subject | Prostate cancer | en_GB |
dc.subject | Prostate-specific antigen | en_GB |
dc.title | Association between patient ethnicity and prostate cancer diagnosis following a prostate-specific antigen test: a cohort study of 730,000 men in primary care in the UK | en_GB |
dc.type | Article | en_GB |
dc.date.available | 2024-03-06T11:17:40Z | |
dc.identifier.issn | 1741-7015 | |
exeter.article-number | 82 | |
exeter.place-of-publication | England | |
dc.description | This is the final version. Available on open access from BMC via the DOI in this record. | en_GB |
dc.description | Availability of data and materials: The data was provided to us under licence from CPRD; therefore, we are unable to share this dataset. | en_GB |
dc.identifier.journal | BMC Medicine | en_GB |
dc.rights.uri | https://creativecommons.org/licenses/by/4.0/ | en_GB |
dcterms.dateAccepted | 2024-01-25 | |
dcterms.dateSubmitted | 2023-09-12 | |
rioxxterms.version | VoR | en_GB |
rioxxterms.licenseref.startdate | 2024-03-01 | |
rioxxterms.type | Journal Article/Review | en_GB |
refterms.dateFCD | 2024-03-06T11:10:41Z | |
refterms.versionFCD | VoR | |
refterms.dateFOA | 2024-03-06T11:17:51Z | |
refterms.panel | A | en_GB |
Files in this item
This item appears in the following Collection(s)
Except where otherwise noted, this item's licence is described as © The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which
permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the
original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or
other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line
to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory
regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this
licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.